About

David Golombos is a urologic oncologist whose research focuses on optimizing surgical outcomes in robotic-assisted procedures for bladder, kidney, and prostate cancers. His work has significantly advanced the understanding of recurrence patterns after robot-assisted radical cystectomy, with a landmark study of 310 patients (47 citations) identifying predictors of atypical metastases like peritoneal carcinomatosis and extrapelvic lymph node spread. Golombos has also pioneered the evaluation of robot-assisted partial cystectomy, demonstrating its perioperative safety and oncological efficacy across diverse clinical scenarios (25 citations). In renal surgery, his population-based analysis of over 18,000 patients (19 citations) compared robotic versus laparoscopic nephrectomy, revealing critical insights into hospital charges and complication rates. He further challenged conventional wisdom by showing that surgical approach does not impact margin status for large renal masses, and his recent work on drain omission during robotic partial nephrectomy and prostatectomy (1 citation, 2024) has implications for streamlining postoperative care. Golombos’ contributions have shaped evidence-based practices in minimally invasive urologic oncology, with his research consistently cited in guidelines and surgical decision-making.

Research Focus

Key Achievements

3
H-Index
5
Papers
95
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Factors Impacting the Occurrence of Local, Distant and Atypical Recurrences after Robot-Assisted Radical Cystectomy: A Detailed Analysis of 310 Patients
47 citations · 2016
📈 Most Prolific Year: 2016 (3 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: New York Hospital Queens, NewYork–Presbyterian Hospital, Stony Brook School, Rutgers, The State University of New Jersey

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago